Market News

Gaztransport & Technigaz SA (GZPZY) Q3 2025 Earnings Call Transcript

Gaztransport & Technigaz SA (OTCPK:GZPZY) Q3 2025 Earnings Call November 3, 2025 2:30 AM EST Company Participants Philippe Berterottière - CEO & Chairman Thierry Hochoa - Director of Administrative & Financial and CFO Conference Call Participants Richard Dawson - Joh. Berenberg, Gossler & Co. KG, Research Division Jean-Luc Romain - CIC Market Solutions (ESN), Research Division Henri Patricot - UBS Investment Bank, Research Division Jamie Franklin - Jefferies LLC, Research Division Kevin Roger - Kepler Cheuvreux, Research Division Jean-Francois Granjon - ODDO BHF Corporate & Markets, Research Division Presentation Operator Good morning.

GZPZY seekingalpha.com • Nov. 3, 2025

LRN Investors Have Opportunity to Join Stride, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Stride, Inc. ("Stride" or "the Company") (NYSE: LRN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

LRN prnewswire.com • Nov. 3, 2025

Stride, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRN

LOS ANGELES , Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Stride, Inc. ("Stride" or "the Company") (NYSE: LRN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.

LRN prnewswire.com • Nov. 3, 2025

80 Mile shares jump on $30 million Greenland joint venture deal

Shares in 80 Mile PLC (AIM:80M, OTCQB:BLLYF) rose as much as 12% in early trading after the explorer agreed a $30 million joint venture with USFM Corporation to develop its Disko-Nuussuaq nickel and copper project in Greenland. Under the binding heads of terms, USFM will fund the investment to earn a 51% stake, while 80 Mile will retain 49% and act as project operator.

GTEC proactiveinvestors.co.uk • Nov. 3, 2025

WPP plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - WPP

LOS ANGELES , Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against  WPP plc ("WPP" or "the Company") (NYSE: WPP ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of WPP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

WPP prnewswire.com • Nov. 3, 2025

Buy The Hidden Backbone: How KLA Benefits From The AI Manufacturing Revolution

KLA stands at the core of the AI-driven semiconductor cycle, enabling precision manufacturing through advanced inspection and metrology systems. Consistent gross margins above 60% and operating margins near 40% highlight a durable competitive moat and strong pricing power. Free cash flow exceeds $4 billion annually, funding R&D, dividends, and buybacks, with over 70% of cash returned to shareholders.

KLAC seekingalpha.com • Nov. 3, 2025

Carnival: Cruising Toward Stronger Earnings And Sharper Margins

Carnival Corporation is a leading cruise company, currently undervalued and trading at a forward P/E of 12.90, below the sector median. CCL posted its 11th consecutive double-beat quarter, with strong revenue and EPS growth, despite a brief negative market reaction post-earnings. A $36 price target suggests a 28% upside over the next 12 months, supported by high margins, steady growth, and robust industry demand.

CCL seekingalpha.com • Nov. 3, 2025

MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before December 2, 2025.

MOH prnewswire.com • Nov. 3, 2025

Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH

LOS ANGELES , Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MOH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

MOH prnewswire.com • Nov. 3, 2025

ITM: Yield Is Most Unattractive Here

VanEck Intermediate Muni ETF tracks intermediate-term, investment-grade municipal bonds, offering tax-free income but only middling returns for the risk taken. ITM's low fees (0.18%) and index-tracking approach provide diversification and lower interest rate risk but limit income potential compared to more selective strategies. Tax-equivalent yields make ITM best suited for investors in higher tax brackets; those below a 24% marginal rate may find better after-tax returns elsewhere.

ITM seekingalpha.com • Nov. 3, 2025

EU Clinical Trial Regulation 536/2014: Compliance, Implementation & Best Practices Training (November 25, 2025)

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "EU Clinical Trial Regulation 536/2014: Compliance, Implementation and Best Practices Training (November 25, 2025)" training has been added to ResearchAndMarkets. com's offering. This course covers the requirements for conducting Clinical Studies across the EU via the requirements of the EU Clinical Trial Regulation (for Drugs and Biologics).

globenewswire.com • Nov. 3, 2025

Global Regulatory Requirements for Drug Safety & Pharmacovigilance: Product Safety, Effective Risk Assessment, and Alignment with Evolving U.S., EU, and UK Regulatory Expectations (November 25, 2025)

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Global Regulatory Requirements for Drug Safety and Pharmacovigilance (November 25, 2025)" training has been added to ResearchAndMarkets. com's offering. This training course is designed to give pharmaceutical and biologic companies operating in the US and EU an introduction to product safety regulatory requirements.

globenewswire.com • Nov. 3, 2025

Sun Care Products Market Research Report 2025: An $18.91 Billion Market by 2030, Driven by Rising Demand for Clean & Natural Formulations, and AI Integration & Smart Beauty

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Sun Care Products Market Research Report 2025-2030" report has been added to ResearchAndMarkets. com's offering. The global sun care products market is expected to grow at a CAGR of 4. 77% from 2024 to 2030 The global sun care products market report consists of exclusive data on 31 vendors.

globenewswire.com • Nov. 3, 2025

Analyzing Grow Capital (GRWC) & The Competition

Volatility and Risk Grow Capital has a beta of 25.26, indicating that its share price is 2,426% more volatile than the S&P 500. Comparatively, Grow Capital's competitors have a beta of -6.48, indicating that their average share price is 748% less volatile than the S&P 500. Insider and Institutional Ownership 52.7% of shares of all

GRWC defenseworld.net • Nov. 3, 2025